L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review.
Wenbo WangDa PanQi LiuXiangjun ChenShaokang WangPublished in: Nutrients (2024)
In summary, LC has demonstrated favorable therapeutic effects in the management of HE, Alzheimer's disease (AD), carpal tunnel syndrome (CTS), CD, migraine, neurofibromatosis (NF), PNSDs, RS, and stroke. However, its efficacy appears to be relatively limited in conditions such as ALS, ataxia, attention deficit hyperactivity disorder (ADHD), depression, chronic fatigue syndrome (CFS), Down syndrome (DS), and sciatica.
Keyphrases
- attention deficit hyperactivity disorder
- autism spectrum disorder
- working memory
- sleep quality
- signaling pathway
- depressive symptoms
- mental health
- atrial fibrillation
- lps induced
- oxidative stress
- early onset
- cognitive decline
- cerebral ischemia
- pi k akt
- nuclear factor
- simultaneous determination
- case report
- inflammatory response
- liquid chromatography
- physical activity
- brain injury
- combination therapy
- drug induced
- cell proliferation